Stopping nucleot(s)ide analogues in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.

Autor: Hall, Samuel A. L.1,2 (AUTHOR) sammy.hall86@gmail.com, Burns, Gareth S.1,2 (AUTHOR), Anagnostou, Despina1 (AUTHOR), Vogrin, Sara2 (AUTHOR), Sundararajan, Vijaya2,3 (AUTHOR), Ratnam, Dilip4,5 (AUTHOR), Levy, Miriam T.6 (AUTHOR), Lubel, John S.7,8 (AUTHOR), Nicoll, Amanda J.9 (AUTHOR), Strasser, Simone I.10,11 (AUTHOR), Sievert, William4,5 (AUTHOR), Desmond, Paul V.1 (AUTHOR), Ngu, Meng C.12 (AUTHOR), Angus, Peter13,14 (AUTHOR), Sinclair, Marie13 (AUTHOR), Meredith, Christopher15 (AUTHOR), Matthews, Gail16 (AUTHOR), Revill, Peter A.17 (AUTHOR), Jackson, Kathy17 (AUTHOR), Littlejohn, Margaret17 (AUTHOR)
Zdroj: Alimentary Pharmacology & Therapeutics. Jul2022, Vol. 56 Issue 2, p310-320. 11p. 2 Charts, 3 Graphs.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje